veeva_event

Top 5 Reasons Why You Should Attend Veeva R&D Summit, Europe

pharmafile | March 15, 2018 | News story | Medical Communications |  biotech, drugs, pharma, pharmaceutical, veeva 

Veeva R&D Summit, Europe is an annual gathering of pharma, biotech and medical devices professionals in clinical, regulatory, quality, and IT.

Now in its fourth year, the event will be hosted at the Fairmont Rey Juan Carlos I on the 12-14 June in Barcelona, and more than 350 delegates are expected to attend.

The agenda features dedicated tracks focused on driving end-to-end business processes across product development.

Advertisement

If you haven’t attended Veeva R&D Summit before, here are the top 5 reasons you shouldn’t miss this conference:

  • Learn from industry leaders. Find out how your peers tackle challenges, such as ensuring inspection-readiness, managing regulatory events, and incorporating partners into key quality processes.
  • Meet the European R&D ecosystem. Wander the partner pavilion to hear from companies such as Accenture, NNIT, and Valiance.
  • See what’s coming next. Discover the latest innovations to improve operations across your development process.
  • Your questions answered by the experts. Meet product management, and experience Veeva Vault applications with hands-on demos, and learn from other users.
  • Have fun. Catch up with your colleagues during the networking opportunities and make new connections.

Find out why previous attendees think Summit is worth attending in this infographic.

The conference is complimentary for qualified attendees. Please reserve your spot today

Rik van Mol

VP, Veeva Vault R&D, Europe

Related Content

Cellbyte raises $2.75m to fund pharma drug launch platform

Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of …

Lilly opens fourth US Gateway Labs site

Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, …

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

The Gateway to Local Adoption Series

Latest content



Pace appoints Ken Beyer as CEO

December 10, 2025